A big announcement from Eli Lilly, its popular obesity drug zep Bound will now be available for purchase on its direct to consumer platform. That means the company is hoping to curb fakes on the black market and make the medication more affordable for those willing to pay out of pocket. The CEO Dave Rick said the company has 2.5 and 5 mg doses, about half the price of its auto injector form and those of its competitors. So we're talking about $349 for the low dose and $549 for the high dose. That's a monthly thing. A B C's Whit Johnson responding to those numbers with the company's CEO still a lot of money. It is. People still would be paying a lot. I mean, that's like a car payment for some people. Can you explain why the cost is still so high? Well, we're of course researching and developing medications. We invented this product. That's an expensive undertaking. We're studying it in over 30 different conditions to prove. Not only do you lose weight, which we've proven, but that benefits your health long term. That's incredibly expensive. As well. The key point is that the the other medication of the class cost about $1000 a month. And here we're bringing that down by about half. I think that's a big, big advance now compared to the auto injector, which is the normal zip bound people may use today. The cheaper version comes boxed in a vial with a needle, you'll have to draw it up yourself and then self inject. So there's another added step, but both work the same way.